Experts urge health regulators to approve 2 ‘turning point’ dementia drugs; donanemab & lecanemab.
Experts urge health regulators to approve 2 ‘turning point’ dementia drugs; donanemab & lecanemab.
www.theguardian.com Experts urge health regulators to approve ‘turning point’ dementia drugs
Exclusive: As results show 35% slowing in cognitive decline, health leaders say swift decisions crucial
![Experts urge health regulators to approve ‘turning point’ dementia drugs](https://lemmy.blahaj.zone/pictrs/image/UT9vwzMTir.jpg?format=webp&thumbnail=256)
0
comments